Chronic pelvic pain (CPP) is complex and often resistant to treatment.
While the exact pathophysiology is unknown, the pain states resultant from conditions such as interstitial cystitis and the like yield patients with a presentation that bears a striking similarity to neuropathic syndromes that are known to respond to neuromodulation. While there has been past success using the sacral region as a target for spinal cord stimulation (SCS) to treat these patients, there remains to be a consensus on the optimal location for lead placement. In this article, the authors discuss the potential etiology of CPP, examine the current literature on lead placement for SCS as a method of treatment, as well as present several cases where novel lead placement was successfully employed.
Hunter C, Davé N, Diwan S, Deer T. Are you the author?
Department of Anesthesiology, Division of Pain Medicine, Weill Cornell Medical College, New York, New York; The Spine and Pain Institute of New York, Staten Island, New York; The Center for Pain Relief, Charleston, West Virginia; Department of Anesthesiology, West Virginia University, Morgantown, West Virginia, U.S.A.
Reference: Pain Pract. 2012 Apr 23. Epub ahead of print.